Pub Date : 2017-12-31DOI: 10.12987/9780300168167-007
{"title":"CHAPTER FIVE GUESTS IN THEIR OWN HOMES","authors":"","doi":"10.12987/9780300168167-007","DOIUrl":"https://doi.org/10.12987/9780300168167-007","url":null,"abstract":"","PeriodicalId":34679,"journal":{"name":"Dubai Diabetes and Endocrinology Journal","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84746289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-12-31DOI: 10.12987/9780300168167-003
{"title":"CHAPTER ONE THE ROOTS OF DUBAI","authors":"","doi":"10.12987/9780300168167-003","DOIUrl":"https://doi.org/10.12987/9780300168167-003","url":null,"abstract":"","PeriodicalId":34679,"journal":{"name":"Dubai Diabetes and Endocrinology Journal","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80558774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-12-31DOI: 10.12987/9780300168167-005
{"title":"CHAPTER THREE IRON CHAINS","authors":"","doi":"10.12987/9780300168167-005","DOIUrl":"https://doi.org/10.12987/9780300168167-005","url":null,"abstract":"","PeriodicalId":34679,"journal":{"name":"Dubai Diabetes and Endocrinology Journal","volume":"72 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76035245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-12-31DOI: 10.12987/9780300168167-009
{"title":"CHAPTER SEVEN THIS IS THE FUTURE?","authors":"","doi":"10.12987/9780300168167-009","DOIUrl":"https://doi.org/10.12987/9780300168167-009","url":null,"abstract":"","PeriodicalId":34679,"journal":{"name":"Dubai Diabetes and Endocrinology Journal","volume":"107 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79348116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-12-31DOI: 10.12987/9780300168167-004
{"title":"CHAPTER TWO BECOMING A GLOBAL BRAND","authors":"","doi":"10.12987/9780300168167-004","DOIUrl":"https://doi.org/10.12987/9780300168167-004","url":null,"abstract":"","PeriodicalId":34679,"journal":{"name":"Dubai Diabetes and Endocrinology Journal","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78658945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Diabetes is often associated with dyslipidemia. Olive oil is known to improve several cardiovascular risk factors. We studied the changes produced in the lipid profile after consumption of olive oil in type 2 diabetic subjects. We studied 45 individuals of both sexes with type 2 diabetes and 15 healthy subject of age 40 years or older. Only subjects not taking medicine for other health conditions and whose fasting blood glucose levels were in the range of 160- 320mg/dl and with high lipids level were included in the study. The study was conducted for 4 weeks. The subjects were allowed to take their routine diet and usual diabetic medicine. They were told to take 30 ml of olive oil per day. Diabetics showed marked dyslipidemia. Four weeks of consumption of olive oil significantly lowered the levels of fasting blood glucose, triglycerides, total cholesterol, and low density lipoproteins in both groups. Reduction was more profound in diabetics than in healthy controls. Meanwhile, high density lipoproteins increased in both groups. Olive oil improved lipid profiles and blood glucose levels in type 2 diabetics.
{"title":"Effects of olive oil on lipid profiles and blood glucose in type2 diabetic patients","authors":"Abdulrahim Al Jamal, A. Ibrahim","doi":"10.1159/000497706","DOIUrl":"https://doi.org/10.1159/000497706","url":null,"abstract":"Diabetes is often associated with dyslipidemia. Olive oil is known to improve several cardiovascular risk factors. We studied the changes produced in the lipid profile after consumption of olive oil in type 2 diabetic subjects. We studied 45 individuals of both sexes with type 2 diabetes and 15 healthy subject of age 40 years or older. Only subjects not taking medicine for other health conditions and whose fasting blood glucose levels were in the range of 160- 320mg/dl and with high lipids level were included in the study. The study was conducted for 4 weeks. The subjects were allowed to take their routine diet and usual diabetic medicine. They were told to take 30 ml of olive oil per day. Diabetics showed marked dyslipidemia. Four weeks of consumption of olive oil significantly lowered the levels of fasting blood glucose, triglycerides, total cholesterol, and low density lipoproteins in both groups. Reduction was more profound in diabetics than in healthy controls. Meanwhile, high density lipoproteins increased in both groups. Olive oil improved lipid profiles and blood glucose levels in type 2 diabetics.","PeriodicalId":34679,"journal":{"name":"Dubai Diabetes and Endocrinology Journal","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81319218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Oguri, Y. Ohyama, Tetsuya Nakamura, S. Tomono, M. Kurabayashi
A prospective randomized open-labeled study was performed to compare the renoprotective effects of enarapril and losartan on the development of microalbuminuria in type 2 diabetic patients with hypertension. Diabetic patients who have hypertension and microalbuminuria at base line (n=19) were recruited. Enarapril (n=11) or losartan (n=8) was randomly chosen by envelope methods and was prescribed for one year. At the end of this study, the blood pressure of patients in these two groups decreased significantly. Urine albumin-creatinine ratio (U-ACR) also decreased in these two groups, however, U-ACR of enarapril group was not significantly different from that of losartan group at any time of this study. Body mass index, HbA1c, blood pressure, and serum lipid profiles were not significantly different between the two groups. From these results, we conclude that the effects of enarapril and losartan on the development of microalbuminuria in type 2 diabetic patients along with hypertension seem to be equivalent in terms of clinical renoprotection.
{"title":"Comparative effects of enarapril versus losartan on the prevention of diabetic nephropathy in type 2 diabetes patients with microalbuminuria","authors":"M. Oguri, Y. Ohyama, Tetsuya Nakamura, S. Tomono, M. Kurabayashi","doi":"10.1159/000497664","DOIUrl":"https://doi.org/10.1159/000497664","url":null,"abstract":"A prospective randomized open-labeled study was performed to compare the renoprotective effects of enarapril and losartan on the development of microalbuminuria in type 2 diabetic patients with hypertension. Diabetic patients who have hypertension and microalbuminuria at base line (n=19) were recruited. Enarapril (n=11) or losartan (n=8) was randomly chosen by envelope methods and was prescribed for one year. At the end of this study, the blood pressure of patients in these two groups decreased significantly. Urine albumin-creatinine ratio (U-ACR) also decreased in these two groups, however, U-ACR of enarapril group was not significantly different from that of losartan group at any time of this study. Body mass index, HbA1c, blood pressure, and serum lipid profiles were not significantly different between the two groups. From these results, we conclude that the effects of enarapril and losartan on the development of microalbuminuria in type 2 diabetic patients along with hypertension seem to be equivalent in terms of clinical renoprotection.","PeriodicalId":34679,"journal":{"name":"Dubai Diabetes and Endocrinology Journal","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89046924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The objectives of this study were to determine the prevalence of diabetes mellitus in Nilufer District, Bursa, Turkey using standardized diagnostic criteria to investigate associated factors, and to determine the risk groups for a preventive public health program. This cross-sectional study was conducted in Nilufer Public Health Training and Research Area, Bursa Province in Turkey. The study population of 727 persons (382 women and 345 men) were selected by a random sampling method. The response rate was 80.6 %. According to the fasting blood glucose levels of the 727 subjects, 44 (6.1 %) were diabetic. In this study, the prevalence of known diabetes was 5.0 %, and the prevalence of previously undiagnosed diabetes was 1.1 %. The ratio of previously undiagnosed to known diabetes was 1:5. Multivariate logistic analyses showed that age (50 and over), family history of diabetes, hypertension and overweight (BMI > 25.0 kg/m2) were risk factors for type 2 diabetes (P < 0.05) in Nilufer District. A public health program in the district should be aimed primarily at these risk groups. The people in the risk groups should be registered and followed-up in a program aimed at preventing overt diabetes. The program can also provide efficient therapy if needed. (Int J Diabetes Metab 14: 98-102, 2006 )
{"title":"Prevalence and associated risk factors of type 2 diabetes mellitus in Nilufer District, Bursa, Turkey","authors":"H. Aksu, Kayıhan Pala, H. Aksu, S. Ersek","doi":"10.1159/000497599","DOIUrl":"https://doi.org/10.1159/000497599","url":null,"abstract":"The objectives of this study were to determine the prevalence of diabetes mellitus in Nilufer District, Bursa, Turkey using standardized diagnostic criteria to investigate associated factors, and to determine the risk groups for a preventive public health program. This cross-sectional study was conducted in Nilufer Public Health Training and Research Area, Bursa Province in Turkey. The study population of 727 persons (382 women and 345 men) were selected by a random sampling method. The response rate was 80.6 %. According to the fasting blood glucose levels of the 727 subjects, 44 (6.1 %) were diabetic. In this study, the prevalence of known diabetes was 5.0 %, and the prevalence of previously undiagnosed diabetes was 1.1 %. The ratio of previously undiagnosed to known diabetes was 1:5. Multivariate logistic analyses showed that age (50 and over), family history of diabetes, hypertension and overweight (BMI > 25.0 kg/m2) were risk factors for type 2 diabetes (P < 0.05) in Nilufer District. A public health program in the district should be aimed primarily at these risk groups. The people in the risk groups should be registered and followed-up in a program aimed at preventing overt diabetes. The program can also provide efficient therapy if needed. (Int J Diabetes Metab 14: 98-102, 2006 )","PeriodicalId":34679,"journal":{"name":"Dubai Diabetes and Endocrinology Journal","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90481109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：